Probiotics for preventing gestational diabetes in overweight or obese pregnant women: A review.
- 2022-12-26
- World journal of clinical cases 10(36)
- Ya-Fang Deng
- Li-Ping Wu
- Yan-Ping Liu
- PubMed: 36683622
- DOI: 10.12998/wjcc.v10.i36.13189
Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit to the host. Specific probiotics or probiotic foods can be used to reduce the risk of diseases associated with aberrant gut microbiota composition. The incidence of gestational diabetes mellitus (GDM) has increased annually with the proportion of overweight and obese people. Overweight or obese pregnant women are at high risk of GDM and have obvious changes in gut microbiota compared with normal-weight pregnant women. Specific probiotics or probiotic foods may alter gut microbiota in overweight or obese pregnant women and inhibit the expression of inflammatory factors, consequently resulting in weight loss and reduced insulin resistance. This review discusses the mechanism of probiotics on GDM, as well as the dose, method and duration of probiotics use, and summarizes current evidence on probiotics in improving glucose metabolism and other maternal and infant outcomes in overweight/obese pregnant women.
Research Insights
| Supplement | Health Outcome | Effect Type | Effect Size |
|---|---|---|---|
| Bifidobacterium longum SP54 | Improved Glucose Metabolism | Beneficial | Small |
| Bifidobacterium longum SP54 | Reduced Prevalence of Gestational Diabetes Mellitus | Beneficial | Small |
| Lactobacillus salivarius UCC118 | Improved Glucose Metabolism | Beneficial | Small |